Blog
13 February, 2025
For the first time, a study by the consultancy firm Afi has evaluated the impact of pharmaceutical companies from a dual perspective: the socio-economic value provided […]
11 February, 2025
37% of all clinical trials being developed in Spain are aimed at treating oncological diseases New drugs are having a direct impact on patient survival, according […]
30 January, 2025
More than 80 pupils from five schools learn about the process of getting medicines to patients: from R&D to clinical trials The “Bringing science to schools” […]
28 January, 2025
The European Medicines Agency approved a total of 114 medicines last year, 46 of which had a new active substance, seven more than the previous year. […]
22 January, 2025
The Coordination Committee of the Technological Platform for Innovative Medicines defines its action plan for 2025 Madrid will host the 18th Annual Conference of Biomedical Research […]
20 January, 2025
Our country is the leader in Europe with 930 clinical studies authorised in 2024. 22% of research to find new drugs is aimed at rare diseases […]
16 January, 2025
The Aemps authorised a total of 930 studies last year, making it the European regulatory agency that approved the most clinical trials, ahead of countries such […]
15 January, 2025
The International Federation of Innovative Pharmaceutical Industry publishes the Facts & Figures 2024 report, which outlines the industry’s contribution globally. In 2023, the industry filed 12,425 […]
20 December, 2024
Pipeline Innovation Review, carried out by the consultancy firm Iqvia for the European Federation of the Pharmaceutical Industry (Efpia) and Vaccines Europe, covers biomedical research underway […]
19 December, 2024
Farmaindustria and Levante-EMV hold a meeting with experts to discuss the creation of the ‘ICAP Guide’ of good practices for the promotion of clinical research in […]
17 December, 2024
The trial, which will evaluate a vaccine under clinical investigation by GSK, will be conducted in Phase I units at La Paz, La Princesa and Puerta […]
5 December, 2024
The percentage of GDP that the state spends on pharmaceuticals has not increased in the last 20 years. Between 2018 and 2023, the increase in the […]
3 December, 2024
The head of Innovation and director of Innovation at Farmaindustria, Miguel González, highlighted how Artificial Intelligence (AI) has brought about a paradigm shift and a revolution […]
20 November, 2024
A report by PwC for the European Federation of the Pharmaceutical Industry shows that the pharmaceutical industry contributes an economic value to the EU of 311,000 […]
18 November, 2024
Farmaindustria presents ‘The pharmaceutical industry and its context in Spain 2024’, the first report that brings together in a single volume all the figures of the […]
15 November, 2024
One year after the presentation of the ‘Guide of good practice recommendations for the promotion of clinical research in primary care’, promoted by Farmaindustria, successful initiatives […]
12 November, 2024
Arantxa Sancho, director of the Department of Medical-Scientific Affairs at Farmaindustria, participates in the informative seminar on pharmacogenomic biomarkers organised by the Aemps. Farmaindustria.es On 29 […]
5 November, 2024
The Farma-Biotech programme facilitates the efficient exchange of information and personal knowledge between research groups, small spin-off companies and the pharmaceutical industry. Since its inception in […]
31 October, 2024
Farmaindustria is leading a project to bring clinical trials to primary care to help decentralise this strategy. laopiniondezamora.es ‘Transforming primary care through clinical trials’ was the […]
29 October, 2024
Assessing Europe’s clinical trial ecosystem, produced by Iqvia for Efpia and Vaccines Europe, shows a 22-12% drop in the share of studies on the continent over […]
24 October, 2024
The Extraordinary General Assembly on Thursday unanimously elected the CEO of Amgen Iberia to lead the Association for the next two years. Source: Farmaindustria.es Fina Lladós […]
22 October, 2024
There are currently more than 600 clinical trials underway for children and adolescents in Spain, almost half of them focused on rare diseases. The Spanish Network […]
8 October, 2024
The closing table of the 5th Symposium of the Healthcare Observatory reviewed the challenges facing the sector. Spain, as a leader of a European health policy’. […]
27 September, 2024
The Clinical Trials Information System (CTIS), managed by the European Medicines Agency (EMA), is a single entry point for the submission and assessment of clinical trial […]
26 September, 2024
From R&D to pharmacovigilance to production and incremental innovation, the industry is constantly seeking to maximise risk reduction in medicines. On World Patient Safety Day, WHO […]
24 September, 2024
Artificial intelligence applied to medical research, top technology trend in 2024 according to the World Economic Forum. Farmaindustria.es Artificial intelligence (AI) is a true revolution […]
19 September, 2024
The report highlights the sector’s contribution to the EU’s R&D and trade balance and recognises the worrying trend of Europe losing ground to other regions of […]
17 September, 2024
The Director General of Farmaindustria, Juan Yermo, presents the sector’s potential and challenges on the second day of the 23rd Annual Meeting of the Pharmaceutical Industry […]
30 July, 2024
1 THE BRAND-NAME DRUG COSTS THE SAME AS ITS GENERIC DRUG Farmaindustria.es Brand-name drugs are at the same price as generic drugs in Spain. The […]
23 July, 2024
For the first time, China has overtaken Europe as the creator of new active ingredients, with 25 compared to the 17 of the old continent, and […]